73/100B285.31
USD
2.32
(0.82%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 2.91Revenue estimate 26.42B
Q4 FY2026 · Earnings report
EPS estimate 2.91Revenue estimate 26.42B
Johnson & Johnson executives and insider trading
Joaquin Duato sold 171,771 shares for 44.71M USD in 4 sales over the last twelve months, the last on 13 August 2026, and bought none on the open market.
Over the last twelve months Johnson & Johnson's insiders sold 325,747 shares for 83.59M USD in 15 sales on the open market, and bought 0 shares in 0 purchases.
Insiders over the last twelve months
- Insider sales
- 15
- Shares sold
- 325,747
- Value sold
- 83.59M USD
- Insider purchasesWhat is insider trading? Insider trading here means the legal trades that a company's executives, directors and large owners make in its shares, reported to the SEC on Form 4.
- 0
Insiders buying against sellingWhat is a Rule 10b5-1 trading plan? A Rule 10b5-1 plan lets an insider fix future trades in advance, while holding no inside information, so later trades follow the plan, not a new decision.
Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
10.14M USD
0
6 months
67.15M USD
0
1 year
83.59M USD
0
2 years
83.59M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance
Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).
Executives and directors
The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.
| Name | Position | Age | Shares sold (12 months) | Value sold (12 months) | Shares bought (12 months) | Last sale | Shares held after |
|---|---|---|---|---|---|---|---|
| Joaquin Duato CEO | Chief Executive Officer & Chairman | 63 | 171,771 | 44.71M USD | — | 13 Aug 2026 | 399,258 |
| James Swanson | Executive Vice President & Chief Information Officer | 60 | 62,080 | 15.11M USD | — | 17 Feb 2026 | 46,219 |
| Timothy Schmid | Executive Vice President & Worldwide Chairman of MedTech | 56 | 23,849 | 6.51M USD | — | 2 Sept 2026 | 47,974 |
| Vanessa Broadhurst | EVP, Global Corp Affairs | — | 23,054 | 5.79M USD | — | 20 Jul 2026 | 46,057 |
| Elizabeth Forminard | Executive Vice President & Chief Legal Officer | 55 | 15,918 | 4.09M USD | — | 6 Aug 2026 | 32,912 |
| Jennifer L Taubert | EVP, WWC. Innovative Medicine | — | 15,000 | 3.95M USD | — | 17 Aug 2026 | 209,451 |
| Kathryn E. Wengel | Executive Vice President and Chief Technical Operations & Risk Officer | 60 | 10,000 | 2.41M USD | — | 11 Jun 2026 | 124,288 |
| Robert J. Decker Jr. | Controller & Chief Accounting Officer | 53 | 4,075 | 1.01M USD | — | 27 Feb 2026 | 27,757 |
| Joseph J. Wolk | Executive Vice President & Chief Financial Officer | 59 | — | — | — | — | — |
| Ryan Koors | Vice President of Investor Relations | — | — | — | — | — | — |
| Dirk Brinckman | Chief Compliance Officer | — | — | — | — | — | — |
| John C. Reed | Executive Vice President of Innovative Medicine and R&D | 68 | — | — | — | — | 35,913 |
| Kristen Blair Mulholland | Executive Vice President & Chief Human Resources Officer | 59 | — | — | — | — | — |
| Daniel E Pinto | Director | — | — | — | — | — | — |
| Eugene A. Woods | Director | — | — | — | — | — | — |
| Marillyn A Hewson | Director | — | — | — | — | — | — |
| Thomas Cavanaugh | EVP WW Chair, Innovative Med. | — | — | — | — | — | 428 |
| Nadja West | Director | — | — | — | — | — | — |
| Mark A Weinberger | Director | — | — | — | — | — | — |
| John G Morikis | Director | — | — | — | — | — | — |
| Mark B. Mcclellan | Director | — | — | — | — | — | — |
| Hubert Joly | Director | — | — | — | — | — | — |
| Paula A Johnson | Director | — | — | — | — | — | — |
| Jennifer A Doudna | Director | — | — | — | — | — | — |
| Mary C Beckerle | Director | — | — | — | — | — | — |
Insider sales and purchases by quarter
How many insider sales and purchases were reported each quarter.
Insider sales Insider purchases
Every insider transactionWhat is insider trading? Insider trading here means the legal trades that a company's executives, directors and large owners make in its shares, reported to the SEC on Form 4.
Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.
| Date | Name | Transaction | Shares | Price | Value | Shares held after | Filing |
|---|---|---|---|---|---|---|---|
| 8 Sept 2026 | Daniel E Pinto | Award | 113 | — | — | 2,445 | Form 4 |
| 8 Sept 2026 | Eugene A. Woods | Award | 136 | — | — | 6,579 | Form 4 |
| 8 Sept 2026 | Marillyn A Hewson | Award | 181 | — | — | 16,049 | Form 4 |
| 2 Sept 2026 | Timothy Schmid | Option exercise | 22,527 | 151.41 | 3.41M USD | 47,974 | Form 4 |
| 2 Sept 2026 | Timothy Schmid | Option exercise | 11,070 | 131.94 | 1.46M USD | 36,517 | Form 4 |
| 2 Sept 2026 | Timothy Schmid | Sale | 22,527 | 274.74 | 6.19M USD | 25,447 | Form 4 |
| 2 Sept 2026 | Timothy Schmid | Option exercise | 11,070 | 131.94 | 1.46M USD | — | Form 4 |
| 2 Sept 2026 | Timothy Schmid | Option exercise | 22,527 | 151.41 | 3.41M USD | — | Form 4 |
| 1 Sept 2026 | Thomas Cavanaugh | Other | — | 156.15 | — | 25,493 | Form 4 |
| 1 Sept 2026 | Thomas Cavanaugh | Other | — | 157.92 | — | 23,311 | Form 4 |
| 1 Sept 2026 | Thomas Cavanaugh | Other | — | 243.45 | — | 15,839 | Form 4 |
| 1 Sept 2026 | Thomas Cavanaugh | Other | — | 162.75 | — | 15,081 | Form 4 |
| 1 Sept 2026 | Thomas Cavanaugh | Other | — | — | — | 2,275 | Form 4 |
| 1 Sept 2026 | Thomas Cavanaugh | Other | — | — | — | 2,097 | Form 4 |
| 1 Sept 2026 | Thomas Cavanaugh | Other | — | — | — | 965 | Form 4 |
| 1 Sept 2026 | Thomas Cavanaugh | Other | — | — | — | 428 | Form 4 |
| 1 Sept 2026 | Thomas Cavanaugh | Other | — | — | — | 71 | Form 4 |
| 17 Aug 2026 | Jennifer L Taubert | Option exercise | 15,000 | 115.67 | 1.74M USD | 209,451 | Form 4 |
| 17 Aug 2026 | Jennifer L Taubert | Sale | 15,000 | 263.36 | 3.95M USD | 194,451 | Form 4 |
| 17 Aug 2026 | Jennifer L Taubert | Option exercise | 15,000 | 115.67 | 1.74M USD | 28,712 | Form 4 |
| 13 Aug 2026 | Joaquin Duato | Option exercise | 123,291 | 115.67 | 14.26M USD | 399,258 | Form 4 |
| 13 Aug 2026 | Joaquin Duato | Sale | 20,976 | 262.00 | 5.50M USD | 378,282 | Form 4 |
| 13 Aug 2026 | Joaquin Duato | Sale | 102,315 | 261.00 | 26.70M USD | 275,967 | Form 4 |
| 13 Aug 2026 | Joaquin Duato | Option exercise | 123,291 | 115.67 | 14.26M USD | — | Form 4 |
| 6 Aug 2026 | Elizabeth Forminard | Option exercise | 9,344 | 131.94 | 1.23M USD | 32,912 | Form 4 |
| 6 Aug 2026 | Elizabeth Forminard | Sale | 9,344 | 257.76 | 2.41M USD | 23,568 | Form 4 |
| 6 Aug 2026 | Elizabeth Forminard | Sale | 6,574 | 255.93 | 1.68M USD | 16,994 | Form 4 |
| 6 Aug 2026 | Elizabeth Forminard | Option exercise | 9,344 | 131.94 | 1.23M USD | — | Form 4 |
| 5 Aug 2026 | Joaquin Duato | Sale | 41,957 | 258.06 | 10.83M USD | 282,490 | Form 4 |
| 5 Aug 2026 | Joaquin Duato | Sale | 6,523 | 258.74 | 1.69M USD | 275,967 | Form 4 |
| 20 Jul 2026 | Vanessa Broadhurst | Option exercise | 11,925 | 131.94 | 1.57M USD | 46,057 | Form 4 |
| 20 Jul 2026 | Vanessa Broadhurst | Option exercise | 11,129 | 129.51 | 1.44M USD | 34,132 | Form 4 |
| 20 Jul 2026 | Vanessa Broadhurst | Sale | 23,054 | 251.27 | 5.79M USD | 23,003 | Form 4 |
| 20 Jul 2026 | Vanessa Broadhurst | Option exercise | 11,129 | 129.51 | 1.44M USD | — | Form 4 |
| 20 Jul 2026 | Vanessa Broadhurst | Option exercise | 11,925 | 131.94 | 1.57M USD | — | Form 4 |
| 11 Jun 2026 | Kathryn E. Wengel | Option exercise | 10,000 | 115.67 | 1.16M USD | 124,288 | Form 4 |
| 11 Jun 2026 | Kathryn E. Wengel | Sale | 10,000 | 241.15 | 2.41M USD | 114,288 | Form 4 |
| 11 Jun 2026 | Kathryn E. Wengel | Option exercise | 10,000 | 115.67 | 1.16M USD | 32,965 | Form 4 |
| 9 Jun 2026 | Eugene A. Woods | Award | 161 | — | — | 6,412 | Form 4 |
| 9 Jun 2026 | Daniel E Pinto | Award | 134 | — | — | 2,321 | Form 4 |
| 9 Jun 2026 | Marillyn A Hewson | Award | 215 | — | — | 15,792 | Form 4 |
| 1 May 2026 | John C. Reed | Option exercise | 25,255 | — | — | 35,913 | Form 4 |
| 1 May 2026 | John C. Reed | Shares withheld for tax | 11,002 | 229.85 | 2.53M USD | 24,911 | Form 4 |
| 1 May 2026 | John C. Reed | Option exercise | 25,255 | — | — | — | Form 4 |
| 23 Apr 2026 | Eugene A. Woods | Award | 975 | — | — | 6,215 | Form 4 |
| 23 Apr 2026 | Nadja West | Award | 975 | — | — | 7,730 | Form 4 |
| 23 Apr 2026 | Mark A Weinberger | Award | 975 | — | — | 12,010 | Form 4 |
| 23 Apr 2026 | Daniel E Pinto | Award | 1,712 | — | — | 2,174 | Form 4 |
| 23 Apr 2026 | John G Morikis | Award | 1,540 | — | — | 1,540 | Form 4 |
| 23 Apr 2026 | Mark B. Mcclellan | Award | 975 | — | — | 21,279 | Form 4 |
| 23 Apr 2026 | Hubert Joly | Award | 975 | — | — | 9,184 | Form 4 |
| 23 Apr 2026 | Paula A Johnson | Award | 975 | — | — | 5,359 | Form 4 |
| 23 Apr 2026 | Marillyn A Hewson | Award | 975 | — | — | 15,488 | Form 4 |
| 23 Apr 2026 | Jennifer A Doudna | Award | 975 | — | — | 10,899 | Form 4 |
| 23 Apr 2026 | Mary C Beckerle | Award | 975 | — | — | 16,798 | Form 4 |
| 10 Mar 2026 | Marillyn A Hewson | Award | 206 | — | — | 14,513 | Form 4 |
| 10 Mar 2026 | Daniel E Pinto | Award | 129 | — | — | 462 | Form 4 |
| 10 Mar 2026 | Eugene A. Woods | Award | 155 | — | — | 5,240 | Form 4 |
| 27 Feb 2026 | Robert J. Decker Jr. | Option exercise | 4,075 | 115.67 | 471.36K USD | 27,757 | Form 4 |
| 27 Feb 2026 | Robert J. Decker Jr. | Sale | 4,075 | 247.87 | 1.01M USD | 23,682 | Form 4 |
| 27 Feb 2026 | Robert J. Decker Jr. | Option exercise | 4,075 | 115.67 | 471.36K USD | — | Form 4 |
| 20 Feb 2026 | Timothy Schmid | Sale | 1,322 | 245.66 | 324.76K USD | 25,447 | Form 4 |
| 17 Feb 2026 | James Swanson | Option exercise | 20,521 | 164.62 | 3.38M USD | 46,219 | Form 4 |
| 17 Feb 2026 | James Swanson | Sale | 20,521 | 242.70 | 4.98M USD | 25,698 | Form 4 |
| 17 Feb 2026 | James Swanson | Option exercise | 20,521 | 164.62 | 3.38M USD | — | Form 4 |
| 15 Feb 2026 | James Swanson | Option exercise | 709 | — | — | 26,007 | Form 4 |
| 15 Feb 2026 | James Swanson | Shares withheld for tax | 309 | 243.45 | 75.23K USD | 25,698 | Form 4 |
| 15 Feb 2026 | James Swanson | Option exercise | 492 | — | — | 25,512 | Form 4 |
| 15 Feb 2026 | James Swanson | Shares withheld for tax | 214 | 243.45 | 52.10K USD | 25,298 | Form 4 |
| 15 Feb 2026 | James Swanson | Award | 19,449 | 243.45 | 4.73M USD | 19,449 | Form 4 |
| 15 Feb 2026 | James Swanson | Option exercise | 709 | — | — | 1,418 | Form 4 |
| 15 Feb 2026 | James Swanson | Award | 1,397 | — | — | 1,397 | Form 4 |
| 15 Feb 2026 | James Swanson | Option exercise | 492 | — | — | 491 | Form 4 |
| 15 Feb 2026 | Kathryn E. Wengel | Option exercise | 635 | — | — | 114,613 | Form 4 |
| 15 Feb 2026 | Kathryn E. Wengel | Option exercise | 606 | — | — | 114,288 | Form 4 |
| 15 Feb 2026 | Kathryn E. Wengel | Shares withheld for tax | 325 | 243.45 | 79.12K USD | 114,288 | Form 4 |
| 15 Feb 2026 | Kathryn E. Wengel | Shares withheld for tax | 310 | 243.45 | 75.47K USD | 113,978 | Form 4 |
| 15 Feb 2026 | Kathryn E. Wengel | Award | 16,945 | 243.45 | 4.13M USD | 16,945 | Form 4 |
| 15 Feb 2026 | Kathryn E. Wengel | Option exercise | 635 | — | — | 1,268 | Form 4 |
| 15 Feb 2026 | Kathryn E. Wengel | Award | 1,217 | — | — | 1,217 | Form 4 |
| 13 Feb 2026 | James Swanson | Option exercise | 22,191 | 162.75 | 3.61M USD | 47,211 | Form 4 |
| 13 Feb 2026 | James Swanson | Option exercise | 19,368 | 165.89 | 3.21M USD | 44,388 | Form 4 |
| 13 Feb 2026 | James Swanson | Option exercise | 9,412 | — | — | 28,567 | Form 4 |
| 13 Feb 2026 | James Swanson | Sale | 22,191 | 243.71 | 5.41M USD | 25,020 | Form 4 |
| 13 Feb 2026 | James Swanson | Sale | 19,368 | 243.76 | 4.72M USD | 25,020 | Form 4 |
| 13 Feb 2026 | James Swanson | Shares withheld for tax | 3,547 | 244.55 | 867.42K USD | 25,020 | Form 4 |
| 13 Feb 2026 | James Swanson | Option exercise | 447 | — | — | 19,298 | Form 4 |
| 13 Feb 2026 | James Swanson | Shares withheld for tax | 143 | 244.55 | 34.97K USD | 19,155 | Form 4 |
| 13 Feb 2026 | James Swanson | Option exercise | 9,412 | — | — | — | Form 4 |
| 13 Feb 2026 | James Swanson | Option exercise | 447 | — | — | — | Form 4 |
| 13 Feb 2026 | James Swanson | Option exercise | 22,191 | 162.75 | 3.61M USD | — | Form 4 |
| 13 Feb 2026 | James Swanson | Option exercise | 19,368 | 165.89 | 3.21M USD | — | Form 4 |
| 13 Feb 2026 | Kathryn E. Wengel | Option exercise | 13,706 | — | — | 120,096 | Form 4 |
| 13 Feb 2026 | Kathryn E. Wengel | Shares withheld for tax | 6,414 | 244.55 | 1.57M USD | 113,682 | Form 4 |
| 13 Feb 2026 | Kathryn E. Wengel | Option exercise | 651 | — | — | 106,607 | Form 4 |
| 13 Feb 2026 | Kathryn E. Wengel | Shares withheld for tax | 217 | 244.55 | 53.07K USD | 106,390 | Form 4 |
| 4 Mar 2025 | Marillyn A Hewson | Award | 75 | — | — | 14,306 | Form 4 |
| 14 Feb 2025 | Thomas Cavanaugh | Other | — | 165.89 | — | 11,906 | Form 4 |
Common questions about Johnson & Johnson's executives and insiders
Source: Financial Modeling PrepVerified against SEC filings